Two more blood pres­sure drugs re­called for po­ten­tial cancer risk

USA TODAY Weekend Extra - - FRONT PAGE -

Teva Phar­ma­ceu­ti­cals has launched a vol­un­tary re­call of two drugs used to treat high blood pres­sure as yet more med­i­ca­tions face con­cerns over a pos­si­ble cancer risk.

The re­call af­fects all lots of com­bi­na­tion tablets fea­tur­ing the drugs am­lodip­ine and val­sar­tan and an­other combo drug fea­tur­ing am­lodip­ine, val­sar­tan and hy­drochloroth­iazide.

The drugs could con­tain an im­pu­rity called N-ni­troso-di­ethy­lamine, which has been clas­si­fied as a pos­si­ble hu­man car­cino­gen, the FDA said. Pa­tients tak­ing either drug should con­tact their doc­tor or phar­ma­cist.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.